Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-Acting Injectable HIV PrEP PROs
Sponsor: Anupama Raghuram MD
Summary
The goal of this observational study is to learn about the real world effectiveness, patient satisfaction and clinical outcomes of LAI PrEP with lenacapavir (LEN) versus cabotegravir (CAB) through surveys and interviews. Participants receiving or initiating LAI PrEP part of their regular medical care will complete surveys and interviews at three study visits over the course of 12 months.
Official title: Improving HIV Prevention Outcomes: Insights on Long-Acting Injectable (LAI) HIV Pre-Exposure Prophylaxis (PrEP) Patient-Reported Medication Preferences, Adherence, and Clinical Outcomes (IMPACT) in a Southern US State
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
128
Start Date
2026-01-15
Completion Date
2028-01
Last Updated
2026-01-30
Healthy Volunteers
No
Conditions
Interventions
Interview and survey to evaluate patient reported outcomes between the two medications.
No intervention, the two cohorts will receive the same surveys and interviews.
Locations (3)
Norton Healthcare
Louisville, Kentucky, United States
University of Louisville, School of Public Health and Information Sciences
Louisville, Kentucky, United States
University of Louisville, Kent School of Social Work
Louisville, Kentucky, United States